Australian Pharmaceutical Industries (API) Stock Price, News & Analysis

Company Overview

Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 453,647 shs
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: 2.29%
• Price Target: N/A
• Consensus Rating: N/A

API Stock Analysis - Frequently Asked Questions

How were Australian Pharmaceutical Industries' earnings last quarter?

Australian Pharmaceutical Industries Limited (ASX:API) posted its quarterly earnings results on Wednesday, April, 17th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.05 by $0.00.

What other stocks do shareholders of Australian Pharmaceutical Industries own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Australian Pharmaceutical Industries investors own include Capricorn Metals (CMM), Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY) and Global X Cloud Computing ETF (CLOU).

Company Calendar

• Last Earnings: 4/17/2019
• Today: 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Business Services
• Industry: Medical Equipment Wholesale
• Sub-Industry: Computer Software
• Current Symbol: ASX:API
• CUSIP: N/A
• CIK: N/A
• Web: www.api.net.au
• Phone: +61-3-88553000
• Fax: N/A
• Employees: 1,310
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: 1.28
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 71.32
• Current Ratio: 1.20
• Quick Ratio: 0.77

Sales & Book Value

• Annual Sales: $4.00 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 8.26
• Book Value: A$0.89 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 492,656,000
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A